Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

3M presents new inhibitors of 5-LO and their use

June 29, 1999

Neutrophil elastase inhibitor Ono-5046 effective in animal model of HCl-induced lung injury

June 28, 1999

Update on Usherdex-4 cystic fibrosis treatment candidate

June 28, 1999

Takeda presents new compounds for asthma, allergic disorders

June 24, 1999

Synsorb Biotech licenses potential cystic fibrosis therapies

June 24, 1999

New treatment for acute cough from Nortran enters clinical testing

June 23, 1999

Duke develops new porphyrins and metal complexes thereof as antioxidants

June 23, 1999

New cell adhesion inhibitors under study at Merck

June 23, 1999

Janssen withdraws antihistamine astemizole from the market

June 22, 1999

Antagonists of P2Y2 receptors designed at Astra (AstraZeneca)

June 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...